Literature DB >> 22875971

Filamentous influenza virus enters cells via macropinocytosis.

Jeremy S Rossman1, George P Leser, Robert A Lamb.   

Abstract

Influenza virus is pleiomorphic, producing both spherical (100-nm-diameter) and filamentous (100-nm by 20-μm) virions. While the spherical virions are known to enter host cells through exploitation of clathrin-mediated endocytosis, the entry pathway for filamentous virions has not been determined, though the existence of an alternative, non-clathrin-, non-caveolin-mediated entry pathway for influenza virus has been known for many years. In this study, we confirm recent results showing that influenza virus utilizes macropinocytosis as an alternate entry pathway. Furthermore, we find that filamentous influenza viruses use macropinocytosis as the primary entry mechanism. Virions enter cells as intact filaments within macropinosomes and are trafficked to the acidic late-endosomal compartment. Low pH triggers a conformational change in the M2 ion channel protein, altering membrane curvature and leading to a fragmentation of the filamentous virions. This fragmentation may enable more-efficient fusion between the viral and endosomal membranes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22875971      PMCID: PMC3457176          DOI: 10.1128/JVI.05992-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

Review 1.  Ras and Rho GTPases: a family reunion.

Authors:  D Bar-Sagi; A Hall
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

2.  Initial structural and dynamic characterization of the M2 protein transmembrane and amphipathic helices in lipid bilayers.

Authors:  Changlin Tian; Philip Fei Gao; Lawrence H Pinto; Robert A Lamb; Timothy A Cross
Journal:  Protein Sci       Date:  2003-11       Impact factor: 6.725

3.  Assembly of endocytic machinery around individual influenza viruses during viral entry.

Authors:  Michael J Rust; Melike Lakadamyali; Feng Zhang; Xiaowei Zhuang
Journal:  Nat Struct Mol Biol       Date:  2004-05-02       Impact factor: 15.369

4.  Rab5 is a signalling GTPase involved in actin remodelling by receptor tyrosine kinases.

Authors:  Letizia Lanzetti; Andrea Palamidessi; Liliana Areces; Giorgio Scita; Pier Paolo Di Fiore
Journal:  Nature       Date:  2004-05-20       Impact factor: 49.962

Review 5.  Endocytosis and intracellular sorting of receptor tyrosine kinases.

Authors:  A Alexander
Journal:  Front Biosci       Date:  1998-07-26

6.  Early stages of influenza virus entry into Mv-1 lung cells: involvement of dynamin.

Authors:  A M Roy; J S Parker; C R Parrish; G R Whittaker
Journal:  Virology       Date:  2000-02-01       Impact factor: 3.616

7.  Reverse genetics studies on the filamentous morphology of influenza A virus.

Authors:  Svetlana V Bourmakina; Adolfo García-Sastre
Journal:  J Gen Virol       Date:  2003-03       Impact factor: 3.891

8.  Influenza virus can enter and infect cells in the absence of clathrin-mediated endocytosis.

Authors:  Sara B Sieczkarski; Gary R Whittaker
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  The M1 matrix protein controls the filamentous phenotype of influenza A virus.

Authors:  C J Elleman; W S Barclay
Journal:  Virology       Date:  2004-03-30       Impact factor: 3.616

10.  Infectious entry pathway of influenza virus in a canine kidney cell line.

Authors:  K S Matlin; H Reggio; A Helenius; K Simons
Journal:  J Cell Biol       Date:  1981-12       Impact factor: 10.539

View more
  65 in total

1.  Determination of cell uptake pathways for tumor inhibitor lysyl oxidase propeptide.

Authors:  Gokhan Baris Ozdener; Manish V Bais; Philip C Trackman
Journal:  Mol Oncol       Date:  2015-08-06       Impact factor: 6.603

2.  Macropinocytosis and Clathrin-Dependent Endocytosis Play Pivotal Roles for the Infectious Entry of Puumala Virus.

Authors:  Sandy Bauherr; Filip Larsberg; Annett Petrich; Hannah Sabeth Sperber; Victoria Klose-Grzelka; Madlen Luckner; Walid Azab; Matthias Schade; Chris Tina Höfer; Maik Joerg Lehmann; Peter T Witkowski; Detlev H Krüger; Andreas Herrmann; Roland Schwarzer
Journal:  J Virol       Date:  2020-07-01       Impact factor: 5.103

3.  Low-Fidelity Assembly of Influenza A Virus Promotes Escape from Host Cells.

Authors:  Michael D Vahey; Daniel A Fletcher
Journal:  Cell       Date:  2018-11-29       Impact factor: 41.582

4.  Epstein-Barr virus transcytosis through polarized oral epithelial cells.

Authors:  Sharof M Tugizov; Rossana Herrera; Joel M Palefsky
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

5.  Single-particle measurements of filamentous influenza virions reveal damage induced by freezing.

Authors:  Jack C Hirst; Edward C Hutchinson
Journal:  J Gen Virol       Date:  2019-12       Impact factor: 3.891

6.  Biological activities of 'noninfectious' influenza A virus particles.

Authors:  Christopher B Brooke
Journal:  Future Virol       Date:  2014-01       Impact factor: 1.831

7.  Sodium hydrogen exchangers contribute to arenavirus cell entry.

Authors:  Masaharu Iwasaki; Nhi Ngo; Juan C de la Torre
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

8.  Structural analysis of respiratory syncytial virus reveals the position of M2-1 between the matrix protein and the ribonucleoprotein complex.

Authors:  Gabriella Kiss; Jens M Holl; Grant M Williams; Eric Alonas; Daryll Vanover; Aaron W Lifland; Manasa Gudheti; Ricardo C Guerrero-Ferreira; Vinod Nair; Hong Yi; Barney S Graham; Philip J Santangelo; Elizabeth R Wright
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

9.  Influences of nanocarrier morphology on therapeutic immunomodulation.

Authors:  Molly Frey; Sharan Bobbala; Nicholas Karabin; Evan Scott
Journal:  Nanomedicine (Lond)       Date:  2018-08-07       Impact factor: 5.307

Review 10.  Protein-lipid interactions critical to replication of the influenza A virus.

Authors:  Petr Chlanda; Joshua Zimmerberg
Journal:  FEBS Lett       Date:  2016-03-30       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.